COR Q2 2019 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q2 2019 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$43.3B+5.6% YoY

Gross Profit

$1.2B2.9% margin

Operating Income

$621M1.4% margin

Net Income

$27M0.1% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

-4.6%

Cash Flow

Operating Cash Flow

$624M

Free Cash Flow

$542M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$38.8B

Total Liabilities

$35.8B

Stockholders' Equity

$2.9B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43.3B	$41.0B	+5.6%
Gross Profit	$1.2B	$1.1B	+10.0%
Operating Income	$621M	$519M	+19.8%
Net Income	$27M	$287M	-90.6%

Revenue Segments

Pharmaceutical Distribution

$41.7B96%

Other Segments

$1.7B4%

Geographic Segments

Other Segments

$1.7B100%